Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7.

The MHC class II molecule of the non-obese diabetic (NOD) mice, I-Ag7, is associated with susceptibility to autoimmune diabetes. To try to understand the molecular basis of this association, we analyzed the peptide binding properties and intracellular behavior of I-Ag7 in comparison with other I-A haplotypes. We found that I-Ag7 molecules manifested normal intracellular trafficking and lifespan, and a small but clearly detectable fraction of I-Ag7 in the cells formed SDS-resistant compact dimers. The binding of an antigenic reference peptide to I-Ag7 was stable and was accompanied by compact dimer formation. Our analysis of the binding specificity of I-Ag7 revealed a peptide binding motif of nine amino acids with a degenerate position at P1 and three conserved anchor positions: P4, P6 and P9. An allele-specific preference for negatively charged residues was found at P9, apparently due to the presence of the rare Ser residue at position 57 of the I-Ag7 beta chain. These findings could have implications for the mechanisms of MHC-mediated susceptibility to autoimmune diabetes in the NOD mice.

[1]  W. McMaster,et al.  Identification of Ia glycoproteins in rat thymus and purification from rat spleen , 1979, European journal of immunology.

[2]  E. Unanue,et al.  The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. , 1996, Journal of immunology.

[3]  R. Karr,et al.  Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association , 1995, The Journal of experimental medicine.

[4]  I. Cohen,et al.  Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  I. Cohen,et al.  Self and foreign 60-kilodalton heat shock protein T cell epitope peptides serve as immunogenic carriers for a T cell-independent sugar antigen. , 1995, Journal of immunology.

[6]  A Sette,et al.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides , 1987, Science.

[7]  R. Busch,et al.  Developing and shedding inhibitions: how MHC class II molecules reach maturity. , 1996, Current opinion in immunology.

[8]  G. Nepom,et al.  Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. , 1996, Journal of immunology.

[9]  J. Todd,et al.  Genetic control of autoimmune diabetes in the NOD mouse. , 1995, Annual review of immunology.

[10]  H. Rammensee,et al.  The peptide binding specificity of the MHC class II I-A molecule of the Lewis rat, RT1.BI. , 1996, International immunology.

[11]  D. Mathis,et al.  Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease , 1993, The Journal of experimental medicine.

[12]  C. Janeway,et al.  Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. , 1994, Journal of immunology.

[13]  H. Mcdevitt,et al.  The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Thorsby,et al.  Identification of a putative motif for binding of peptides to HLA-DQ2. , 1996, International immunology.

[15]  R. Germain,et al.  The biochemistry and cell biology of antigen processing and presentation. , 1993, Annual review of immunology.

[16]  Emil R. Unanue,et al.  Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell , 1994, Nature.

[17]  M Levitt,et al.  Molecular dynamics of native protein. II. Analysis and nature of motion. , 1983, Journal of molecular biology.

[18]  M. Levitt,et al.  Molecular dynamics of native protein. I. Computer simulation of trajectories. , 1983, Journal of molecular biology.

[19]  E. Unanue,et al.  Identification of two distinct properties of class II major histocompatibility complex-associated peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  W. Wooster,et al.  Crystal structure of , 2005 .

[21]  L. Steinman,et al.  Escape from “horror autotoxicus”: Pathogenesis and treatment of autoimmune disease , 1995, Cell.

[22]  Antonio Lanzavecchia,et al.  Irreversible association of peptides with class II MHC molecules in living cells , 1992, Nature.